What steroid dose is appropriate during infection, particularly after stopping extracorporeal membrane oxygenation (ECMO) within the first two weeks?

Steroid Dosing During Infection After ECMO Discontinuation

For critically ill patients with infection after stopping ECMO within the first 2 weeks, use low-dose hydrocortisone <400 mg/day (typically 200-300 mg/day) for at least 3 days if septic shock is present and unresponsive to fluids and moderate-to-high-dose vasopressors; otherwise, avoid corticosteroids for infection without shock.

Clinical Decision Algorithm

Step 1: Assess Hemodynamic Status

• Septic shock present (requiring vasopressors >0.1 μg/kg/min norepinephrine equivalent after adequate fluid resuscitation):

  • Initiate corticosteroids 1, 2

• Sepsis without shock:

  • Do not use corticosteroids - they provide no mortality benefit and increase hyperglycemia risk 1

Step 2: Agent Selection and Dosing

Hydrocortisone is the preferred agent based on the most robust trial evidence 2:

• Dose: 200-300 mg/day IV
• Administration options:
  • Continuous infusion (preferred for steady levels) with 50-100 mg bolus first
  • OR 50 mg IV bolus every 6 hours 2
• Duration: 7-14 days at full dose, or shorter if rapidly improving 2
• Minimum treatment: At least 3 days at full dose 1

Alternative agents (if hydrocortisone unavailable): Dexamethasone, methylprednisolone, or prednisolone produce similar results, though differences are likely small 2

Step 3: Special Considerations for Post-ECMO Patients

Critical nuance: ECMO patients face heightened infection risk 3, 4. In the post-ECMO period:

• Steroid use itself increases nosocomial infection risk during ECMO 3
• Higher cumulative doses (>165 mg dexamethasone-equivalent over 14 days) correlate with increased hospital-acquired infections 5
• Balance is essential: Use steroids only when hemodynamically indicated (septic shock), not prophylactically for infection risk alone

Monitoring Requirements

Mandatory monitoring during steroid therapy 2:

• Blood glucose (treat hyperglycemia aggressively)
• Serum sodium (watch for hypernatremia)
• Serum potassium (monitor for hypokalemia)
• Signs of secondary infection (especially in post-ECMO patients who are already high-risk 3, 4)

Discontinuation Strategy

Tapering considerations 2:

• Courses <14 days: May stop abruptly with close monitoring
• Courses >14 days: Consider tapering to prevent adrenal insufficiency
• Monitor closely after stopping: Watch for recurrent inflammation, shock, or need for mechanical ventilation
• If deterioration occurs after stopping: Consider reinitiating steroids (though speculative) 2

Critical Pitfalls to Avoid

1. Do not use high-dose, short-course steroids (≥400 mg/day hydrocortisone) - associated with worse outcomes compared to low-dose, long-course 1

2. Do not use steroids for sepsis without shock - no mortality benefit, only harm from hyperglycemia 1

3. Do not ignore infection risk in post-ECMO patients - they have 37.6 nosocomial infections per 1000 ECMO days 3, and steroids compound this risk

4. Do not abruptly stop steroids after prolonged courses without monitoring for adrenal insufficiency 2

Evidence Quality Note

The recommendations are based on conditional recommendations with low-quality evidence from major guidelines 1, 2. The 2017 SCCM/ESICM guidelines 1 and 2018 BMJ clinical practice guideline 2 provide the strongest framework. The Cochrane meta-analysis of 33 RCTs (4,268 patients) showed mortality benefit only with low-dose, long-duration therapy in septic shock 1. No specific ECMO-steroid dosing trials exist, so standard septic shock protocols apply with heightened infection vigilance.